← Open Payments lookup

KENDALL BROWN: Open Payments

NPI 1194100701 · LOGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,098 in 55 payments from 10 companies in 2025. Trend: 2023 $784 · 2024 $1,046 · 2025 $1,098

Food & beverage: $987Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.21$356
Neurocrine BioSciences, Inc.11$180
Teva Pharmaceuticals USA, Inc.4$147
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$122
Vanda Pharmaceuticals Inc.3$69
Lundbeck LLC4$66
E.R. Squibb & Sons, L.L.C.3$62
Alkermes, Inc.2$43
ABBVIE INC.2$36
Janssen Pharmaceuticals, Inc1$17

Products named: ABILIFY ASIMTUFII, INGREZZA, CAPLYTA, REXULTI, FANAPT, COBENFY, VRAYLAR, UZEDY.

Industry payments across UT — which companies pay providers there.